NICE's independent advisory committee has said the five AI technologies - CAD EYE, ENDO-AID, EndoScreener, GI Genius and MAGENTIQ-COLO - can be used in the NHS while more evidence is collected over the next four years to understand their full benefits.
These AI tools watch the live camera feed during a colonoscopy and have learned to spot polyps by studying thousands of images. When the software thinks it sees a polyp, it alerts the doctor to the area of concern.
The doctor stays in complete control and makes all the decisions. The whole process fits into the normal colonoscopy and usually adds just a minute or two to the appointment.
Dr Anastasia Chalkidou, HealthTech programme director at NICE, said: ‘These AI technologies work like a helpful assistant during bowel examinations, flagging up areas that doctors might want to take a second look at. By helping to spot more polyps, these tools could potentially save lives by catching problems before they develop into cancer.'
She added: ‘We're allowing these technologies to be used now because they show real promise, whilst we gather the detailed evidence, we need to understand their long-term impact on preventing cancer.'
Professor Neil Hawkins, vice-chair of the NICE diagnostics advisory committee, said: ‘The committee saw clear evidence that these AI tools can help doctors find more polyps during bowel examinations. However, we need more information to fully understand how this translates into preventing cancer and saving lives in the long run.'
Professor Hawkins added: ‘That's why we're recommending they can be used whilst companies collect more detailed evidence. It's vital to remember that AI supports doctors' expertise – it doesn't replace their skill and judgement in caring for patients.'
This guidance supports the government's commitment to transforming cancer care and getting diagnoses faster. The government's 10-Year Health Plan is focused on shifting care closer to home and using the latest technology to improve patient outcomes.
Health innovation minister, Dr Zubir Ahmed, said: ‘It is so exciting to be able to harness this technology to ensure patients have their cancers spotted early – in some cases before they've had a chance to develop – and arm our NHS with rigorously tested and evidenced clinical AI tools.
‘Our 10-Year Health Plan will ensure patients get the care they need and make the NHS the most AI-enabled healthcare system in the world, as we shift from analogue to digital and sickness to prevention.'
Professor Peter Johnson, national clinical director for cancer at NHS England,added: ‘AI technologies are a really exciting step forward for patients, giving our clinicians an extra tool to spot problems like harmful growths sooner when they're far easier to remove and prevent cancers from developing.
‘We're committed to bringing innovative technology into frontline care quickly and safely as part of the NHS's move from analogue to digital, and this is a perfect example of that. I am looking forward to seeing how this technology works in NHS services, alongside the appropriate clinical oversight – and the benefits it has for patients.'
A consultation on the draft recommendations has now begun and comments can be submitted via nice.org.uk until Thursday 11 December 2025.
